𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Japanese experience with second-line chemotherapy with low-dose (60 mg/m2) docetaxel in patients with advanced non-small-cell lung cancer

✍ Scribed by Toru Mukohara; Koji Takeda; Masaki Miyazaki; Nobuhide Takifuji; Kazuhiko Terakawa; Shunichi Negoro


Publisher
Springer
Year
2001
Tongue
English
Weight
79 KB
Volume
48
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Phase II trial of a 75-mg/m2 dose of doc
✍ Vincent A. Miller; James R. Rigas; Prudence A. Francis; Stefan C. Grant; Katheri πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 493 KB πŸ‘ 2 views

## Background. A prior Phase I1 study of a 100-mg/m2 dose of docetaxel conducted at the Memorial Sloan-Kettering Cancer Center (New York, NY) demonstrated a 38% response rate with grade 3 or 4 neutropenia in 76% of the patients and a grade 2 or greater rash or infusionrelated reaction in 41% and 3